Maze Therapeutics Stock

mazetx.comHealthcareFounded: 2018Funding to Date: $383.9MM

Maze Therapeutics is a biotechnology company focused on developing novel therapeutics to treat genetic diseases. The company's mission is to address the underlying genetic causes of disease and enable the development of targeted therapies that can improve patients' lives.

Register for Details

For more details on financing and valuation for Maze Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Maze Therapeutics.

Register Today

Other companies like Maze Therapeutics in the Healthcare sector

Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$809.52MM
Sector
Last Round Est. Valuation
$1.01B
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 
Sector
Last Round Est. Valuation
$396.01MM
Sector
Last Round Est. Valuation
$400.53MM
Sector
Last Round Est. Valuation
$1.53B